LSX - partnering for Life Science eXecutives

LSX - partnering for Life Science eXecutives

Information Services

London, London 4,908 followers

Connecting biotech, medtech & healthtech decision makers. Brought to you by Informa Connect.

Follow

About us

LSX is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. Our community helps catalyse early stage innovation through peer-to-peer education and knowledge sharing, networking, partnering and deal making to champion the most innovative and exciting ideas. We bring deals to life. LSX are now part of Informa Connect. We have combined forces with the world’s leading producer of live events and we’re excited about the opportunities this move will bring for our clients and colleagues. LSX will continue to bring you the world-class partnering, investment and strategy events that made our name.

Website
https://www.lsxleaders.com/
Industry
Information Services
Company size
11-50 employees
Headquarters
London, London
Type
Public Company
Founded
2014
Specialties
Business and Market Intelligence, Conferences and Events, and Connections and Partnering

Locations

  • Primary

    Suite 132

    Business Design Centre, 52 Upper St.

    London, London N1 0QH, GB

    Get directions

Employees at LSX - partnering for Life Science eXecutives

See all employees

Updates

  • LSX - partnering for Life Science eXecutives reposted this

    View organization page for BioXconomy, graphic
    BioXconomy

    104 followers

    BioXconomy, your latest life science partnering site, is now live! 🚀 I am excited to announce the launch of BioXconomy, a brand-new publication bringing you the latest insights into partnering, innovation, and investment in the life sciences space. Since shifting from the editorship of biomanufacturing news site BioProcess Insider four months ago, some of you may be asking what I’ve been up to? Well, I’ve been working and writing behind the scenes to focus on the launch of BioXconomy, the media partner for Informa Connect Life Sciences flagship brands EBD Group, LSX - partnering for Life Science eXecutives, and partneringONE. I am thoroughly looking forward to seeing this publication grow and want to thank everyone for their hard work to make this happen. Subscribe to our newsletter by visiting the link below and clicking on "stay updated." Feel free to reach out to me via LinkedIn or at [email protected] to hear more or share your news and views. Happy Tuesday, happy reading, and here’s to our new publication. Best, Millie Nelson Editor, BioXconomy

    BioXconomy

    BioXconomy

    bioxconomy.com

  • View organization page for LSX - partnering for Life Science eXecutives, graphic
    LSX - partnering for Life Science eXecutives

    4,908 followers

    🌟 Webinar: Navigating the Evolving Pharma M&A Landscape: Trends, Challenges, and Opportunities 🌟 📅 Tuesday, October 23rd, 2024 🕙 10:00 AM EST Join us for an in-depth discussion on the dynamic world of pharmaceutical M&A. Our panel of experts will share their insights on: - Trends shaping the Pharma M&A landscape - Navigating regulatory and compliance challenges - Assessing valuation and due diligence strategies - Unlocking value and integration success Join Panellists: - Oliver Barnes, US Pharmaceutical & Biotech Correspondent, Financial Times - Christian Schenk, Investment Director, Apposite Capital - Konstantina Katcheves, SVP, Global Business Development and Acquisitions, Teva Pharmaceuticals - Corey Brown, Partner, M&A Practice Group Co-Chair, Foley Hoag - Michelle Li, Vice President and Head, BD&L Transactions, Bristol Myers Squibb  Stay ahead in the rapidly evolving M&A environment by understanding the latest trends and overcoming key challenges. 🔗 https://lnkd.in/ezfGJAzb #Pharma #MandA #BusinessDevelopment

    This content isn’t available here

    Access this content and more in the LinkedIn app

  • View organization page for LSX - partnering for Life Science eXecutives, graphic
    LSX - partnering for Life Science eXecutives

    4,908 followers

    🌟 Webinar: AI-Powered Insights: Revolutionizing Pharma BD Deals 🌟 📅 Tuesday, June 11, 2024 🕒 2:00 PM BST Discover how AI is transforming pharmaceutical business development. Join industry leaders as they explore the impact of AI on deal-making, including: - Strategic decision-making with data intelligence - Optimizing deal valuation and risk assessment - Enhancing due diligence and partner selection - Driving innovation through AI collaboration Panelists: - Roby Kanichay, Head of Technologies and Externalizations Business Development, Merck Group - David Linson, Senior Director-Business Operations and Intelligence, Eli Lilly and Company - Alexandria Athanasiou Hall, Head of Industry, LifeSciences, AlphaSense - Ivan Griffin, Co-Founder, BenevolentAl - Steve Lehmann, Director, Venture Operations, Portal Innovations Don't miss out on this opportunity to learn from experts shaping the future of pharma BD. 🔗 [Register now] https://lnkd.in/exb_MbWs #Pharma #BusinessDevelopment #AI #Innovation

    This content isn’t available here

    Access this content and more in the LinkedIn app

Affiliated pages

Similar pages

Browse jobs